Rational design and synthesis of 6-aryl-6H-benzo[c]chromenes as non-steroidal progesterone receptor antagonists for use against cancers
- 9 January 2021
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 32, 116003
- https://doi.org/10.1016/j.bmc.2021.116003
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
This publication has 29 references indexed in Scilit:
- Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen speciesOncotarget, 2015
- Practical and Highly Selective C-H Functionalization of Structurally Diverse EthersAngewandte Chemie, 2014
- The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer MetastasisMedicinal Research Reviews, 2014
- Control of cell cycle transcription during G1 and S phasesNature Reviews Molecular Cell Biology, 2013
- Catalyzed Selective Direct α‐ and γ‐Alkylation of Aldehydes with Cyclic Benzyl Ethers by Using T+BF4− in the Presence of an Inexpensive Organic Acid or AnhydrideChemistry – A European Journal, 2011
- The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic ConformationOnline Journal of Public Health Informatics, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- A new generation of progesterone receptor modulatorsSteroids, 2008
- A semiempirical free energy force field with charge‐based desolvationJournal of Computational Chemistry, 2007
- 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: A Novel Class of Nonsteroidal Human Progesterone Receptor AgonistsJournal of Medicinal Chemistry, 1998